EU Regulatory Roundup, June 2019: Screws Tighten And Debate Intensifies Over System Readiness
There has been an unprecedented focus this month on notified bodies. Their readiness is pivotal in terms of the EU’s new medtech regulatory system being able to function on time.
You may also be interested in...
With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.
Non-CE-marked products on the EU market, virtual notified body audits, free standards and the Commission bid to pause the MDR. March has seen unprecedented developments as COVID-19 has railroaded through the sector decimating regulatory rules and plans.
Suppliers to the UK’s National Health Service from outside the EU could save up to 12% in costs for some equipment during COVID-19 emergency measures as the UK tries to increase supplies